Searched over 200M research papers
6 papers analyzed
These studies suggest that rosuvastatin calcium is generally well-tolerated and effective in lowering cholesterol and improving cardiovascular health, with no significant adverse reactions reported.
20 papers analyzed
Rosuvastatin calcium is a widely used statin medication primarily prescribed to manage high cholesterol and prevent cardiovascular diseases. While it is effective in lowering lipid levels and reducing inflammation, it is essential to understand its potential side effects, especially in different patient populations.
One of the most frequently reported side effects of rosuvastatin calcium is gastrointestinal discomfort. This can include symptoms such as nausea, abdominal pain, and constipation. These side effects are generally mild and tend to resolve on their own without the need for medical intervention.
Muscle-related side effects, including myalgia (muscle pain) and muscle weakness, are also common with rosuvastatin calcium. These symptoms can range from mild discomfort to more severe conditions like rhabdomyolysis, although the latter is rare. Monitoring for muscle pain is crucial, especially in patients on higher doses .
Rosuvastatin calcium can cause elevations in liver enzymes, which may indicate liver damage. Regular monitoring of liver function tests is recommended for patients on this medication to detect any potential liver issues early.
In patients undergoing hemodialysis, rosuvastatin calcium has been shown to effectively lower cholesterol levels and reduce inflammation. However, these patients need to be closely monitored for any adverse effects due to their compromised health status.
For patients with coronary heart disease, especially those who have undergone percutaneous coronary intervention (PCI), rosuvastatin calcium is effective in improving lipid profiles and reducing inflammatory markers. Higher doses have been associated with better outcomes but also come with an increased risk of side effects such as muscle pain and liver enzyme abnormalities .
In individuals with metabolic syndrome, rosuvastatin calcium has been found to improve insulin resistance. However, these patients should be monitored for any changes in blood glucose levels and potential liver enzyme elevations.
Rosuvastatin calcium can interact with other medications, such as telmisartan and amlodipine, commonly prescribed for hypertension and dyslipidemia. These interactions can alter the pharmacokinetic profile of rosuvastatin, potentially increasing the risk of side effects. However, studies have shown that these interactions are generally not clinically significant, and the treatments are well-tolerated.
While rosuvastatin calcium is effective in managing cholesterol levels and reducing cardiovascular risk, it is associated with several side effects, including gastrointestinal issues, muscle pain, and liver enzyme abnormalities. These side effects can vary based on the patient population and dosage. Regular monitoring and appropriate dose adjustments can help mitigate these risks, ensuring the safe and effective use of rosuvastatin calcium.
Most relevant research papers on this topic